DBS Buy Rating Pfizer: Proven Investment Strategy
DBS Buy Rating Pfizer highlights a positive outlook on the pharmaceutical giant’s stock performance and future potential.
DBS Buy Rating Pfizer highlights a positive outlook on the pharmaceutical giant’s stock performance and future potential.
Capri Global Capital redemption details announced, revealing the record date for ₹732715 commercial paper. Stay informed!
Natco Pharma rights issue offers shareholders a significant opportunity to invest in the company.